Brian P. Warren
Net Worth

Last updated:

What is Brian P. Warren net worth?

The estimated net worth of Mr. Brian P. Warren is at least $19,717,181 as of 5 Nov 2021. He owns shares worth $7,360,453 as insider, has earned $6,785,428 from insider trading and has received compensation worth at least $5,571,300 in Cencora.

What is the salary of Brian P. Warren?

Mr. Brian P. Warren salary is $557,130 per year as Senior Vice President of Devel. & Product Engineering in Cencora.

How old is Brian P. Warren?

Mr. Brian P. Warren is 55 years old, born in 1970.

What stocks does Brian P. Warren currently own?

As insider, Mr. Brian P. Warren owns shares in one company:

Company Title Shares Price per share Total value
Cencora (COR) Senior Vice President of Devel. & Product Engineering 25,121 $293 $7,360,453

What does Cencora do?

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Brian P. Warren insider trading

Cencora

Mr. Brian P. Warren has made 38 insider trades between 2015-2021, according to the Form 4 filled with the SEC. Most recently he sold 850 units of COR stock worth $130,577 on 5 Nov 2021.

The largest trade he's ever made was exercising 10,931 units of COR stock on 4 Nov 2019. As of 5 Nov 2021 he still owns at least 25,121 units of COR stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 850 $153.62 $130,577
Sale
Common Stock 850 $139.95 $118,957
Sale
Common Stock 850 N/A N/A
Sale
Common Stock 1,856 $77.52 $143,872
Sale
Common Stock 1,425 $110.26 $157,125
Sale
Common Stock 1,425 $27.04 $38,536
Sale
Common Stock 4,950 $127.03 $628,799
Option
Stock Option (Right to Buy) 3,880 $32.4 $125,712
Option
Common Stock 4,950 $34.01 $168,350
Sale
Common Stock 1,000 $127.14 $127,140
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 $120 $120,000
Sale
Common Stock 1,000 $102.79 $102,790
Sale
Common Stock 1,223 $99.61 $121,825
Sale
Common Stock 560 $103.6 $58,016
Sale
Common Stock 1,547 $110.44 $170,851
Option
Stock Option (Right to Buy) 1,534 $28.2 $43,251
Option
Common Stock 1,534 $28.2 $43,251
Sale
Common Stock 1,534 $117.55 $180,322
Option
Common Stock 10,931 $20.2 $220,806
Sale
Common Stock 10,931 $118.59 $1,296,307
Option
Stock Option (Right to Buy) 10,931 $20.2 $220,806
Sale
Common Stock 2,000 $108.69 $217,374
Sale
Common Stock 2,000 $113.34 $226,670
Sale
Common Stock 560 $101.22 $56,683
Sale
Common Stock 1,801 $100.98 $181,865
Sale
Common Stock 2,000 $101.76 $203,520
Sale
Common Stock 623 $101.37 $63,154
Sale
Common Stock 1,000 $96.56 $96,555
Sale
Common Stock 10,000 $115.11 $1,151,100
Sale
Common Stock 1,000 $114.27 $114,270
Sale
Common Stock 1,000 $104.52 $104,520
Sale
Common Stock 4,365 $97.71 $426,504
Sale
Common Stock 1,120 $96.52 $108,102
Sale
Common Stock 1,247 $94.21 $117,484
Sale
Common Stock 1,242 $91.98 $114,233
Sale
Common Stock 409 $87.96 $35,976
Sale
Common Stock 408 $88.81 $36,234
Sale
Common Stock 258 $90.16 $23,261
Sale
Common Stock 300 $70.76 $21,227
Sale
Common Stock 422 $64.89 $27,383
Sale
Common Stock 410 $65.24 $26,748
Sale
Common Stock 267 $64.41 $17,197
Sale
Common Stock 360 $56.25 $20,251

Cencora key executives

Cencora executives and other stock owners filed with the SEC: